Optimization of 131I activity value required for thyroid remnants and metastatic lesions ablation in children with differentiated thyroid cancer

被引:0
|
作者
Kozak, OV [1 ]
Shishkina, VV [1 ]
Korchinskaya, OL [1 ]
Sagan, DL [1 ]
Dzhuza, DA [1 ]
Trocevskiy, VV [1 ]
机构
[1] Ukraine Acad Med Sci, Inst Oncol, UA-03022 Kiev, Ukraine
关键词
thyroid cancer in children; I-131;
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
66 children with differentiated thyroid cancer have been treated with I'll after thyroidectomy. Activities administered amounted from 370 to 5600 MBq. Patients were divided into three groups according to scintigraphy data: Group 1-with thyroid remnants only (25 patients), Group 2-with metastatic lesions in lymph nodes (15 patients), Group 3-with metastatic lesions in lungs (26 patients). The aim of the study was to evaluate parameters of radioiodine accumulation and excretion in remnants during radioiodine treatment in children after thyroidectomy, to determine the influence of I'll activity value on the result of the first course of radioiodine treatment. The fraction (f) of patients with thyroid remnants ablation after first course of the treatment within each specified activity range has been calculated and plotted against each interval of I-131 activity. In Group 3 number of courses required for total ablation of thyroid tissue was evaluated as a function of activities administered. In Group 1 f has a constant value (about 0.55) within the range of 1000-2500 MBq followed by the abrupt increase (up to 1) at 2500 MBq remaining at this plateau value with further increase of activity. In Group 3 number of courses of radioiodine treatment largely depends first activity value, namely the greater is first activity value the less is number of courses required for total ablation of remnants and metastatic lesions. The activity 2500 MBq could be considered as an optimal value for thyroid remnants ablation after first course of radioiodine treatment in children without metastatic lesions accumulating radioiodine, while in groups with metastatic lesions, for minimizing number of courses, first activity should be not less then 4000 MBq.
引用
收藏
页码:221 / 224
页数:4
相关论文
共 50 条
  • [1] Ablation of the thyroid remnant and 131I dose in differentiated thyroid cancer
    Doi, SAR
    Woodhouse, NJY
    CLINICAL ENDOCRINOLOGY, 2000, 52 (06) : 765 - 773
  • [2] Influence of the 131I activity on the probability of remnants ablation in thyroid cancer patients
    Kozak, OV
    EXPERIMENTAL ONCOLOGY, 2001, 23 (04): : 291 - 293
  • [3] Radiation dose to the testes after 131I therapy for ablation of postsurgical thyroid remnants in patients with differentiated thyroid cancer
    Ceccarelli, C
    Battisti, P
    Gasperi, M
    Fantuzzi, E
    Pacini, F
    Gualdrini, G
    Pierantoni, MC
    Luciani, A
    Djokich, D
    Pinchera, A
    JOURNAL OF NUCLEAR MEDICINE, 1999, 40 (10) : 1716 - 1721
  • [4] Teff and thyroid remnants/blood activity ratio upon 131I therapy of patients with differentiated thyroid cancer
    Kozak, OV
    Chebotareva, ED
    Sinuta, BF
    Shishkina, VV
    EXPERIMENTAL ONCOLOGY, 2001, 23 (01): : 71 - 72
  • [5] Required therapeutic dose of 131I for thyroid ablation after surgery for differentiated thyroid carcinoma
    Yaneva, M.
    Botushanova, A.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2013, 40 : S399 - S399
  • [6] Dosimetric approach to 131I ablation therapy for the differentiated thyroid cancer
    Gortan, Fatma Arzu
    Yuksel, Alptug Ozer
    Gulaldi, Nedim Cuneyt Murat
    Coskun, Nazim
    Akca, Ceren Deniz Kapulu
    HELLENIC JOURNAL OF NUCLEAR MEDICINE, 2022, 25 (03) : 260 - 268
  • [7] Low activity treatment with 131I in differentiated thyroid cancer
    Olivan-Sasot, P.
    Prado-Wohlwend, S.
    Sanchez-Vano, R.
    Yepes-Agudelo, A.
    Agudelo-Cifuentes, M.
    Bernal-Vergara, J.
    Bello-Arques, P.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2018, 45 : S608 - S609
  • [8] Prescribed Activity of 131I Therapy in Differentiated Thyroid Cancer
    Van Nostrand, Douglas
    JOURNAL OF NUCLEAR MEDICINE, 2017, 58 (05) : 697 - 699
  • [9] Post-surgical ablation of thyroid remnants with high-dose 131I in patients with differentiated thyroid carcinoma
    Arslan, N
    Ilgan, S
    Serdengecti, M
    Ozguven, MA
    Bayhan, H
    Okuyucu, K
    Gulec, SA
    NUCLEAR MEDICINE COMMUNICATIONS, 2001, 22 (09) : 1021 - 1027
  • [10] Influencing factors of the first 131I ablation therapy for children and adolescents differentiated thyroid cancer
    Lina, L.
    Tian, T.
    Bin, L.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2019, 46 (SUPPL 1) : S622 - S622